Regulatory Considerations for Physiological Closed-Loop Controlled Medical Devices Used for Automated Critical Care: Food and Drug Administration Workshop Discussion Topics.
PMID : 28763355 · 2018
B, a, h, r, a, m, , P, a, r, v, i, n, i, a, n, ;, , C, h, r, i, s, t, o, p, h, e, r, , S, c, u, l, l, y, ;, , H, a, n, n, i, e, b, e, y, , W, i, y, o, r, ;, , A, l, l, i, s, o, n, , K, u, m, a, r, ;, , S, a, n, d, y, , W, e, i, n, i, n, g, e, r
Publicité
Résumé
Part of the mission of the Center for Devices and Radiological Health (CDRH) at the US Food and Drug Administration is to facilitate medical device innovation. Therefore, CDRH plays an important role in helping its stakeholders such as manufacturers, health care professionals, patients, patient advocates, academia, and other government agencies navigate the regulatory landscape for medical devices. This is particularly important for innovative physiological closed-loop controlled (PCLC) devices
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.